Autolus Therapeutics plc - AUTL
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Armistice Capital, LLC | 6.58% | 17,500,000 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Steven Boyd | 6.58% | 17,500,000 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | MAK Capital Fund LP | 11.3% | 30,005,343 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | MAK Capital One L.L.C. | 11.3% | 30,005,343 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Michael A. Kaufman | 11.3% | 30,005,343 | View |
| Dec 03, 2025 | SCHEDULE 13G/A | MAK Capital Fund LP | 10.1% | 26,887,508 | View |
| Dec 03, 2025 | SCHEDULE 13G/A | MAK Capital One L.L.C. | 10.1% | 26,887,508 | View |
| Dec 03, 2025 | SCHEDULE 13G/A | Michael A. Kaufman | 10.1% | 26,887,508 | View |
| Nov 14, 2025 | SCHEDULE 13G | Armistice Capital, LLC | 5.86% | 15,600,000 | View |
| Nov 14, 2025 | SCHEDULE 13G | Steven Boyd | 5.86% | 15,600,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Capital, LP | 0.97% | 2,568,613 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 0.97% | 2,568,613 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | David Kroin | 0.97% | 2,568,613 | View |
| Oct 06, 2025 | SCHEDULE 13G/A | Wellington Management Group LLP | 0.0% | 0 | View |
| Oct 06, 2025 | SCHEDULE 13G/A | Wellington Group Holdings LLP | 0.0% | 0 | View |
| Oct 06, 2025 | SCHEDULE 13G/A | Wellington Investment Advisors Holdings LLP | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.